Literature DB >> 36047771

Most cancers carry a substantial deleterious load due to Hill-Robertson interference.

Susanne Tilk1, Svyatoslav Tkachenko2, Christina Curtis3,4,5, Dmitri A Petrov1, Christopher D McFarland2.   

Abstract

Cancer genomes exhibit surprisingly weak signatures of negative selection (Martincorena et al., 2017; Weghorn, 2017). This may be because selective pressures are relaxed or because genome-wide linkage prevents deleterious mutations from being removed (Hill-Robertson interference; Hill and Robertson, 1966). By stratifying tumors by their genome-wide mutational burden, we observe negative selection (dN/dS ~ 0.56) in low mutational burden tumors, while remaining cancers exhibit dN/dS ratios ~1. This suggests that most tumors do not remove deleterious passengers. To buffer against deleterious passengers, tumors upregulate heat shock pathways as their mutational burden increases. Finally, evolutionary modeling finds that Hill-Robertson interference alone can reproduce patterns of attenuated selection and estimates the total fitness cost of passengers to be 46% per cell on average. Collectively, our findings suggest that the lack of observed negative selection in most tumors is not due to relaxed selective pressures, but rather the inability of selection to remove deleterious mutations in the presence of genome-wide linkage.
© 2022, Tilk et al.

Entities:  

Keywords:  Hill-Robertson interference; cancer evolution; evolutionary biology; genetics; genomics; human; mutation load

Year:  2022        PMID: 36047771      PMCID: PMC9499534          DOI: 10.7554/eLife.67790

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  56 in total

1.  Beneficial mutations, hitchhiking and the evolution of mutation rates in sexual populations.

Authors:  T Johnson
Journal:  Genetics       Date:  1999-04       Impact factor: 4.562

Review 2.  Approximate Bayesian Computation (ABC) in practice.

Authors:  Katalin Csilléry; Michael G B Blum; Oscar E Gaggiotti; Olivier François
Journal:  Trends Ecol Evol       Date:  2010-05-18       Impact factor: 17.712

3.  Identification and characterization of essential genes in the human genome.

Authors:  Tim Wang; Kıvanç Birsoy; Nicholas W Hughes; Kevin M Krupczak; Yorick Post; Jenny J Wei; Eric S Lander; David M Sabatini
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

4.  Universal distribution of protein evolution rates as a consequence of protein folding physics.

Authors:  Alexander E Lobkovsky; Yuri I Wolf; Eugene V Koonin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

5.  Synonymous mutations frequently act as driver mutations in human cancers.

Authors:  Fran Supek; Belén Miñana; Juan Valcárcel; Toni Gabaldón; Ben Lehner
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

6.  The effect of linkage on limits to artificial selection.

Authors:  W G Hill; A Robertson
Journal:  Genet Res       Date:  1966-12       Impact factor: 1.588

Review 7.  The evolutionary consequences of erroneous protein synthesis.

Authors:  D Allan Drummond; Claus O Wilke
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

8.  A Big Bang model of human colorectal tumor growth.

Authors:  Andrea Sottoriva; Haeyoun Kang; Zhicheng Ma; Trevor A Graham; Matthew P Salomon; Junsong Zhao; Paul Marjoram; Kimberly Siegmund; Michael F Press; Darryl Shibata; Christina Curtis
Journal:  Nat Genet       Date:  2015-02-09       Impact factor: 38.330

9.  Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells.

Authors:  Bret R Williams; Vineet R Prabhu; Karen E Hunter; Christina M Glazier; Charles A Whittaker; David E Housman; Angelika Amon
Journal:  Science       Date:  2008-10-31       Impact factor: 47.728

Review 10.  Mutational signatures: the patterns of somatic mutations hidden in cancer genomes.

Authors:  Ludmil B Alexandrov; Michael R Stratton
Journal:  Curr Opin Genet Dev       Date:  2013-12-29       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.